Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Sutro Biopharma Inc (STRO)

Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Sutro Biopharma Reports Third Quarter 2024 Financial Results and Progress on IND Applications and Clinical Trials Quiver Quantitative, Inc. - Thu Nov 14, 1:52AM CST

Sutro Biopharma reports significant advancements in ADC technology, ongoing trials, and robust financial resources.Quiver AI SummarySutro Biopharma, Inc. announced in its third-quarter 2024 financial results...

STRO : 2.75 (-4.84%)
Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights GlobeNewswire - Wed Nov 13, 3:30PM CST

STRO : 2.75 (-4.84%)
Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference GlobeNewswire - Mon Nov 4, 3:05PM CST

STRO : 2.75 (-4.84%)
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML GlobeNewswire - Fri Nov 1, 7:00AM CDT

STRO : 2.75 (-4.84%)
Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum GlobeNewswire - Thu Oct 10, 3:05PM CDT

STRO : 2.75 (-4.84%)
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players Newswire.ca - Thu Sep 19, 11:08AM CDT

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

ONCY : 0.9950 (+1.53%)
NVS : 103.04 (-0.02%)
LNTH : 76.22 (-0.79%)
STRO : 2.75 (-4.84%)
ZYME : 14.91 (-3.12%)
ONC.TO : 1.39 (+0.72%)
Recent Breakthroughs in Cancer Research Could Impact These Key Companies BayStreet.ca - Thu Sep 19, 10:52AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – In the oncology world, there’s...

ONCY : 0.9950 (+1.53%)
ONC.TO : 1.39 (+0.72%)
NVS : 103.04 (-0.02%)
LNTH : 76.22 (-0.79%)
STRO : 2.75 (-4.84%)
ZYME : 14.91 (-3.12%)
Author
Why Investors Are Suddenly Excited About Vaxcyte MarketBeat - Mon Oct 31, 2022

Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet.

PCVX : 86.49 (-0.39%)
PFE : 24.86 (+0.24%)
MRNA : 39.51 (+7.22%)
STRO : 2.75 (-4.84%)
MRK : 96.56 (+0.26%)
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones Globe Newswire - Mon Aug 8, 2022

- Collaboration with Astellas on discovery and development of iADCs for up to three targets, includes an upfront payment of $90 million and $422.5 million...

STRO : 2.75 (-4.84%)
Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference Globe Newswire - Wed Aug 3, 2022

SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology...

STRO : 2.75 (-4.84%)

Barchart Exclusives

Can Nvidia Stock Rally After Q3 Earnings This Week? Barchart - Mon Nov 18, 2:39PM CST
Valued at a market cap of $3.5 trillion, Nvidia is a big tech giant that continues to grow at an enviable pace, even as major earnings beats have become routine. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot